DEA ephedrine final rule would require behind-the-counter retail sale.
This article was originally published in The Tan Sheet
Executive Summary
DEA EPHEDRINE RULE WOULD REQUIRE BEHIND-THE-COUNTER RETAIL SALE of single-ingredient products as part of the General Security Requirements of the new regulation. The final rule, published in the June 22 Federal Register, implements the Domestic Chemical Diversion Control Act of 1993.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning